Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Understand what makes a retirement plan good. Evaluate essential elements for a successful retirement strategy.
20,725 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A new funding framework is here. The housing 21st century brings new loan options and smarter ways to build and prese...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
A sizable stake emerged as H&R Block faced a meaningful slide. This article breaks down what a block stock down inves...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
Cathie Wood’s approach to downturns leans into disciplined bargain hunting. This article breaks down the idea of cath...
Oklo stock fell further as traders digested quarterly results and a new regulatory filing. This article breaks down w...
As Nvidia continues to ride AI-driven demand, the 2027 earnings outlook blends growth in data centers, gaming resilie...
Investors are rethinking where to place bets as AI hype cools. Transportation stocks offer diversification and exposu...
In May, iren limited rallied almost 40% as investors priced in AI growth, earnings signals, and a new Nvidia partners...
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...